Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Q&A
Pharma & Biotech
Training Cell Therapies: DeciBio Q&A with Brian Feth (CEO) and James Lim (CSO) of Xcell Biosciences
In this Q&A with Brian Feth (CEO) and James Lim (CSO) of Xcell Biosciences, they share their journey into cell therapies, discussing the need for tools to modulate conditions, the critical step in enabling cell therapies to target solid tumors, and the importance of automation and bespoke manufacturing workflows in advancing the field.
January 17, 2024
DeciBio Q&A
Pharma & Biotech
Training Cell Therapies: DeciBio Q&A with Brian Feth (CEO) and James Lim (CSO) of Xcell Biosciences
In this Q&A with Brian Feth (CEO) and James Lim (CSO) of Xcell Biosciences, they share their journey into cell therapies, discussing the need for tools to modulate conditions, the critical step in enabling cell therapies to target solid tumors, and the importance of automation and bespoke manufacturing workflows in advancing the field.
January 17, 2024
Cell & Gene Tx
Infographic
Clinical Diagnostics
DeciBio NGS DxBook - Solid Tumor Panels
The evolving landscape of NGS in clinical oncology reveals intriguing trends, especially for solid tumor panels.
January 15, 2024
Infographic
Clinical Diagnostics
DeciBio NGS DxBook - Solid Tumor Panels
The evolving landscape of NGS in clinical oncology reveals intriguing trends, especially for solid tumor panels.
January 15, 2024
DeciBio News
DxBooks Data Insights
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | December Roundup 2023
Liquid Biopsy (LBx) continued to develop through December, featuring new clinical and research collaborations as well as trial launches and study results.
January 12, 2024
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | December Roundup 2023
Liquid Biopsy (LBx) continued to develop through December, featuring new clinical and research collaborations as well as trial launches and study results.
January 12, 2024
Liquid Biopsy
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | December Roundup 2023
Read about the latest updates in the Next-Generation Therapeutics space in the month of December.
January 9, 2024
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | December Roundup 2023
Read about the latest updates in the Next-Generation Therapeutics space in the month of December.
January 9, 2024
Next-Generation Therapeutics
In The Press
Pharma & Biotech
CGT in 2024 – Blue Skies Ahead?
Our cell and gene therapy practice experts highlight their predictions for the field in 2024.
January 9, 2024
In The Press
Pharma & Biotech
CGT in 2024 – Blue Skies Ahead?
Our cell and gene therapy practice experts highlight their predictions for the field in 2024.
January 9, 2024
Life Science Consulting
Cell & Gene Tx
In The Press
Pharma & Biotech
2023 ADC Roundup: A Year Of Collaboration And Licensing Deals
Despite the continuation of a poor funding climate in biotech, 2023 was a big year for antibody-drug conjugates (ADCs).
January 5, 2024
In The Press
Pharma & Biotech
2023 ADC Roundup: A Year Of Collaboration And Licensing Deals
Despite the continuation of a poor funding climate in biotech, 2023 was a big year for antibody-drug conjugates (ADCs).
January 5, 2024
adjuvant cell therapy
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved